MORGAN LOTZ: Open Payments
NPI 1972075752 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 28 payments from 16 companies in 2025. Trend: 2023 $1,007 · 2024 $1,168 · 2025 $1,047
Food & beverage: $770Education: $277
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 3 | $209 |
| Janssen Biotech, Inc. | 2 | $132 |
| Ipsen Biopharmaceuticals, Inc | 2 | $101 |
| SOBI, INC | 1 | $99 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Celgene Corporation | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| PFIZER INC. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: XT CDX, RYBREVANT, Doptelet, KEYTRUDA, Enhertu, ZIIHERA, REBLOZYL, XPOVIO.
Industry payments across IL — which companies pay providers there.
